The Personal Care Products Council v. Bonta

CourtDistrict Court, E.D. California
DecidedJune 12, 2024
Docket2:23-cv-01006
StatusUnknown

This text of The Personal Care Products Council v. Bonta (The Personal Care Products Council v. Bonta) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Personal Care Products Council v. Bonta, (E.D. Cal. 2024).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 EASTERN DISTRICT OF CALIFORNIA 10 11 THE PERSONAL CARE PRODUCTS No. 2:23-cv-01006-TLN-JDP COUNCIL, 12 Plaintiff, 13 ORDER v. 14 ROB BONTA, 15 Defendant. 16

17 18 This matter is before the Court on Proposed Defendant-Intervenor Environmental Health 19 Advocates, Inc.’s (“EHA”) Motion to Intervene. (ECF No. 19.) Plaintiff The Personal Care 20 Products Council (“Plaintiff”) and Defendant Rob Bonta, in his official capacity as California 21 Attorney General (“Defendant”), filed oppositions. (ECF Nos. 21, 22.) EHA filed a reply (ECF 22 No. 26). 23 Also before the Court is Plaintiff’s Motion for a Preliminary Injunction. (ECF No. 27.) 24 Defendant filed an opposition (ECF No. 30), and Plaintiff filed a reply (ECF No. 32). 25 For the reasons set forth below, the Court DENIES EHA’s Motion to Intervene and 26 GRANTS Plaintiff’s Motion for a Preliminary Injunction. 27 /// 28 /// 1 I. FACTUAL AND PROCEDURAL BACKGROUND 2 This case arises out of Plaintiff’s challenge to California’s Safe Drinking Water and Toxic 3 Enforcement Act of 1986 (“Prop 65”) insofar as it requires businesses to post cancer warnings 4 about the presence of titanium dioxide in certain products they sell to California consumers. 5 Plaintiff is a nonprofit business association with a membership of approximately 600 businesses 6 in the cosmetic industry. (ECF No. 1 at ¶ 16.) Plaintiff’s members are involved in the supply 7 chain for cosmetic and personal care products that contain titanium dioxide, and Plaintiff 8 advocates on their behalf before various government bodies. (Id.) Defendant is the Attorney 9 General of the State of California and is tasked with enforcing Prop 65. (Id. ¶ 17.) 10 A. Relevant Background on Prop 65 11 Prop 65 is a “right-to-know” law that requires the Governor to publish and maintain a list 12 of chemicals known to the State of California to cause cancer or reproductive toxicity (“Prop 65 13 List”). Cal. Health & Safety Code § 25249.8(a). A chemical is known to the state to cause 14 cancer or reproductive toxicity if: (1) in the opinion of the state’s qualified experts, it has been 15 clearly shown — through scientifically valid testing according to generally accepted principles — 16 to cause cancer or reproductive toxicity; (2) a body considered to be authoritative by the state’s 17 qualified experts has formally identified it as causing cancer or reproductive toxicity; or (3) an 18 agency of the state or federal government has formally required it to be labeled or identified as 19 causing cancer or reproductive toxicity. Id. § 25249.8(b). The Prop 65 List must also include 20 those substances listed as human or animal carcinogens by the International Agency for Research 21 on Cancer (“IARC”), and any substance within the scope of the federal Hazard Communication 22 Standard. Id. § 25249.8(a); Cal. Lab. Code § 6382(b)(1), (d). 23 Absent an exemption, Prop 65 requires businesses with ten or more employees to provide 24 a clear and reasonable warning to consumers before knowingly and intentionally exposing them 25 to chemicals on the Prop 65 List.1 Cal. Health & Safety Code §§ 25249.5, 25249.6, 25249.11(b). 26 1 Businesses are exempt from the warning requirement if: (1) the warning would be 27 preempted by federal law; (2) the exposure takes place less than twelve months after the chemical in question is added to the Prop 65 List; or (3) the business can show exposure to a chemical on 28 the Prop 65 List does not pose a significant health risk, assuming lifetime exposure at specified 1 Regulations implementing Prop 65 provide guidance to businesses and examples of what 2 constitutes a “clear and reasonable” warning. Cal. Code Regs. tit. 27, § 25601 et seq. For 3 example, for exposures to listed carcinogens, a business may provide a warning consisting of a 4 black exclamation point inside a yellow equilateral triangle with a bold black outline and the 5 word “WARNING” appearing in all capital letters and bold print, alongside the words, “This 6 product can expose you to chemicals including [name of one or more chemicals], which is [are] 7 known to the State of California to cause cancer. For more information go to 8 www.P65Warnings.ca.gov.” Id. § 25603(a). Alternatively, for listed carcinogens, businesses 9 may provide a short-form warning using the same yellow triangle and exclamation point and the 10 word “WARNING” in all capital letters and bold print, alongside the words “Cancer -- 11 www.P65Warnings.ca.gov.” Id. § 25603(b). A warning that complies with these regulations is 12 considered a “safe harbor warning” and is presumptively “clear and reasonable” under Prop 65. 13 Id. § 25601(a). 14 Prop 65 may be enforced by the government — including the Attorney General and 15 certain local prosecutors — or by private individuals in the public interest when various 16 conditions are met. Cal. Health & Safety Code § 25249.7(c)–(d). Courts may enjoin violations 17 of Prop 65 and/or assess civil monetary penalties of up to two thousand five hundred dollars 18 ($2,500) per day for each violation. Id. § 25249.7(a)–(b)(1). 19 B. Titanium Dioxide and Prop 65 20 1. Overview of Titanium Dioxide 21 Titanium dioxide was first produced commercially in 1923, primarily for pigment 22 production. (ECF No. 27-3 at 85.) Titanium dioxide is comprised of various minerals and is 23 commonly used in cosmetic and personal care products, including toothpaste, sunscreen, and 24 makeup. (ECF No. 1 at ¶ 2; ECF No. 27-1 at 11; ECF No. 27-3 at 85.) The U.S. Food and Drug 25 Administration has determined titanium dioxide may be safely used in these products with some 26 limitations. See 21 C.F.R. §§ 73.1575(b) (color additive in drugs), 73.2575(b) (cosmetics), 27

28 levels. Id. § 25249.10(a)–(c). 1 73.575(c) (color additive in foods), 352.10 (sunscreen). “Listed Titanium Dioxide” is a specific 2 type of titanium dioxide that consists of airborne, unbound particles of respirable size. (ECF No. 3 1 at ¶ 3.) Listed Titanium Dioxide is at issue in this case. (Id. at 27.) 4 2. IARC Study 5 IARC was founded in the 1960s by the United States and other members of the United 6 Nations as the cancer research arm of the World Health Organization. (ECF No. 30 at 11; ECF 7 No. 27-3 at 4.) In 1969, the IARC initiated a program on the evaluation of the carcinogenic risk 8 of various chemicals to humans. (ECF No. 27-3 at 4; ECF No. 30 at 11.) The objective of the 9 program is to, among other things, publish critical reviews of data on carcinogenicity for agents to 10 which humans are known to be exposed. (ECF No. 27-3 at 4.) IARC is considered an 11 authoritative source by California’s qualified experts, and thus, substances it lists as human or 12 animal carcinogens must be included on the Prop 65 List. Cal. Health & Safety Code § 13 25249.8(a); Cal. Lab. Code § 6382(b)(1). 14 In 2010, IARC published its findings that there is inadequate evidence for the 15 carcinogenicity of titanium dioxide in humans but sufficient evidence for the carcinogenicity of 16 titanium dioxide in experimental animals. (ECF No. 27-3 at 88; ECF No. 27-1 at 11–12; ECF 17 No. 30 at 12.) As a result, IARC concluded titanium dioxide is “possibly carcinogenic to humans 18 (Group 2B).”2 (ECF No. 27-3 at 88; ECF No. 30 at 12.) IARC based its Group 2B cancer 19 classification for titanium dioxide primarily on two studies involving experimental rats that 20 inhaled titanium dioxide where an increased rate of lung tumors was observed. (ECF No. 27-3 at

21 2 IARC classifies chemicals into one of four graduated categories: Group 1, Group 2A, Group 2B, or Group 3.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell v. Morrison
26 U.S. 351 (Supreme Court, 1828)
Wooley v. Maynard
430 U.S. 705 (Supreme Court, 1977)
University of Texas v. Camenisch
451 U.S. 390 (Supreme Court, 1981)
Edenfield v. Fane
507 U.S. 761 (Supreme Court, 1993)
Brown v. California Department of Transportation
321 F.3d 1217 (Ninth Circuit, 2003)
Prete v. Bradbury
438 F.3d 949 (Ninth Circuit, 2006)
Mazurek v. Armstrong
520 U.S. 968 (Supreme Court, 1997)
Perry v. Proposition 8 Official Proponents
587 F.3d 947 (Ninth Circuit, 2009)
John Doe v. Kamala Harris
772 F.3d 563 (Ninth Circuit, 2014)
Cindy Garcia v. Google, Inc.
786 F.3d 733 (Ninth Circuit, 2015)
Drakes Bay Oyster Company v. Sally Jewell
747 F.3d 1073 (Ninth Circuit, 2013)
Kevin Cooper v. Gavin Newsom
13 F.4th 857 (Ninth Circuit, 2021)
Riley's American Heritage Farm v. James Elsasser
32 F.4th 707 (Ninth Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
The Personal Care Products Council v. Bonta, Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-personal-care-products-council-v-bonta-caed-2024.